ABSTRACT
INTRODUCTION
Endometrial cancer is the most common malignancy of the female genital tract in developed countries with a cumulative risk of 1.8% 1 . The reported number of newly diagnosed cases in Europe was 100 000 in 2012, with an age-standardized annual incidence of 14.7 per 100 000 women 1 . Prognosis depends on the patient's age, histological type of malignancy, tumor grade, lymphovascular space invasion, tumor size, depth of myometrial invasion, cervical stromal invasion and tumor involvement of the lower uterine segment [2] [3] [4] . Prognosis is excellent in most women with Stage-I disease, with a 5-year survival rate of 96%. However, the prognosis is worse for women with high-risk endometrial cancer (Grade 3 or non-endometrioid histotype and/or Stage ≥ IB), because these women are at increased risk of lymph node metastasis, distant tumor spread and tumor recurrence 5 . Thus, identification of high-risk patients preoperatively is important, in order to tailor treatment and achieve optimal long-term survival.
Tumor size, depth of myometrial invasion and cervical stromal involvement cannot be determined by clinical examination. Therefore, ultrasound and magnetic resonance imaging (MRI) are being used increasingly to improve preoperative evaluation, i.e. to identify women in need of more extensive surgery including pelvic-and para-aortic lymph node dissection [6] [7] [8] . According to the European Society of Gynaecological Oncology (ESGO), the European Society for Medical Oncology (ESMO) and the European Society of Radiotherapy and Oncology (ESTRO), the preoperative workup should include pelvic examination, transvaginal or transrectal ultrasonography, and pathological assessment of an endometrial biopsy (histological type and grade) 5 . To optimize the sonographic assessment of endometrial tumors, a better understanding of the association between sonographic features and tumor stage, grade and histological type is needed.
The aim of this study was to describe the sonographic features of endometrial cancer in relation to histological type, tumor grade and stage using the International Endometrial Tumor Analysis (IETA) 9 examination technique and terminology.
METHODS
This was a prospective cross-sectional multicenter study of women with biopsy-confirmed endometrial cancer, who were examined using transvaginal ultrasound according to the IETA study protocol. Patients were recruited between 1 January 2011 and 31 December 2015 from 17 European ultrasound centers (Table S1 ). We aimed to recruit consecutive women, in order to avoid selection bias, and to include at least 1500 patients to be able to perform subanalyses on non-endometrioid histological types and on premenopausal women. We excluded women who did not undergo hysterectomy or who had hysterectomy later than 120 days after the ultrasound examination, those with final diagnosis other than endometrial cancer, those with tumor duplicity (i.e. other synchronous gynecological malignancy), those with incomplete ultrasound information, and those lost to follow-up.
The research protocol was approved by the local Ethics Committee or Review Board at each center. Hysterectomy and bilateral salpingo-oophorectomy were performed by laparotomy, vaginally or via minimally invasive techniques such as laparoscopy or robotic surgery. Systematic pelvic and para-aortic lymphadenectomy was performed to stage high-risk tumors according to local protocols. The International Federation of Gynecology and Obstetrics (FIGO) 2009 staging criteria were used, based on surgical findings at hysterectomy 4 . Ultrasound examinations were performed by the affiliated investigators at each center using the standardized examination and measurement techniques described in the IETA consensus statement ( Figure S1 ) 9 . All ultrasound examinations were performed by gynecologists with extensive experience in gynecological ultrasound, using high-end ultrasound equipment, i. All women were examined in the lithotomy position with an empty bladder. The uterus was scanned in the sagittal plane from cornu to cornu and in the transverse plane from the cervix to the fundus. The presence of adenomyosis and fibroids was noted. The anteroposterior diameter of the uterus and endometrium (endometrial thickness) was measured in the sagittal plane, and the laterolateral diameter of the uterus (uterine width) in the transverse plane. In the presence of endometrial tumor, its three orthogonal diameters (anteroposterior (tumor thickness) and craniocaudal (tumor length) diameters in the sagittal plane, and laterolateral diameter (tumor width) in the transverse plane) were measured, as well as the minimal tumor-free margin and the distance from the outer cervical os to the lowest margin of the tumor (Figure 1 ). The minimal tumor-free margin was measured in any plane in which the distance from the tumor to the serosa appeared to be the smallest. Tumor volume was calculated from the three orthogonal tumor diameters, using the approximate formula for an ellipsoid:
Having established an overview of the whole uterus, the ultrasound image was magnified to contain only the uterine corpus. The magnified image was used when describing the endometrial grayscale ultrasound morphology and vascularization using color/power Doppler according to IETA 9 terms and definitions ( Figure S1 ). Color/power Doppler examinations were carried out at pulse repetition frequency (PRF) of 0.3-0.9 kHz, with the gain and PRF adjusted so that vessels were clearly defined without 'blooming'.
The research protocol contained questions regarding each patient's medical, reproductive and vaginal bleeding history, demographic and biometric variables, and sonographic variables. Data were entered into internet-based data capture software (Clinical Data Miner (https:// cdm.esat.kuleuven.be)) 10 that included pictograms of all IETA ultrasound variables. Examiners were encouraged to enter and save ultrasound data on the day of the ultrasound examination. Incomplete data could not be saved. Once saved, the data were locked and no changes could be made. Results regarding histology and tumor stage were entered following hysterectomy. In all centers, a pathologist with substantial experience in gynecological oncology assessed the pathological specimens. The histopathological variables assessed were histological type, grade of differentiation, and pathological stage. Only epithelial malignant tumors, i.e. endometrial carcinomas (endometrioid adenocarcinoma, mucinous adenocarcinoma, serous carcinoma, clear-cell carcinoma, mixed-cell carcinoma, undifferentiated carcinoma), and mixed epithelial and mesenchymal malignant tumors, i.e. carcinosarcomas, were included 11 . Endometrioid adenocarcinomas were classified into three grades (Grade 1, well differentiated; Grade 2, moderately differentiated; Grade 3, poorly differentiated). Low-risk endometrial cancer was defined as Stage IA Grades 1-2. High-risk endometrial cancer was classified into three groups to allow assessment of the presence of association between ultrasound features and stage, grade or histological type: To assess the ability of an ultrasound variable to discriminate between low-and high-risk cancer, and between low (Grade 1 or 2) and high (Grade 3) tumor grade, a univariable logistic regression model was fitted and the c-statistic was calculated (equivalent to the area under the receiver-operating characteristics curve) with 95% CI 12 ; 95% CIs for the difference in percentages were calculated using a Wilson-score-based method without continuity correction 13 ; 95% CIs for the difference in medians were based on the percentile method using 1000 stratified bootstrap samples. The value of the c-statistic represents the probability of distinguishing correctly between patients with and those without the outcome of interest based on the value of the ultrasound variable. A c-statistic of 0.5 indicates no predictive ability, whereas a c-statistic of 1 indicates perfect discriminative ability. Statistical analysis was performed using R 3.2.4 (https:// www.r-project.org/).
RESULTS
A total of 1714 women were recruited into the study. Of these, 176 women were excluded: in 118 women hysterectomy was either not performed (due to comorbidities), or data could not be retrieved because the surgery was carried out at another hospital, or hysterectomy was performed more than 120 days after the ultrasound examination; 25 women had final diagnosis other than endometrial cancer or uterine carcinosarcoma (cervical cancer (n = 4), synchronous ovarian cancer (n = 3), synchronous tubal cancer (n = 2), endometrial stromal sarcoma (n = 8), adenosarcoma (n = 2), leiomyosarcoma (n = 4), uterine tumor resembling ovarian sex cord tumor (n = 1), perivascular epithelioid cell tumor (n = 1)); in 26 cases endometrial morphology assessment was not complete because the examiners did not fill out correctly the Study Protocol; five women were excluded due to duplicate entries and data for two patients could not be identified due to error in the identification key.
Therefore, 1538 women were included in the final analysis. Their demographic background data and histological diagnoses are presented in Table 1 . Ninety percent (range between centers, 80-100%) of the women were postmenopausal, of which 85% (range between centers, 69-95%) reported abnormal uterine bleeding and 12% (range between centers, 0-26%) used systemic hormone replacement therapy or vaginal estrogens (estriol or estradiol). Endometrial cancer was of Stage IA in 61% (range between centers, 49-87%) of the patients, and 86.5% (range between centers, 71-100%) of tumors were endometrioid.
Sonographic characteristics of non-endometrioid and endometrioid tumors in relation to their grade are presented in Table 2 . Higher grade of endometrioid cancer was associated with thicker endometrium, higher tumor volume, lower proportion of tumors with regular endometrial-myometrial junction and of tumors with uniform echogenicity, and higher proportion of tumors with multiple vessels of focal or multifocal origin and of higher color score. The strongest discriminators of highcompared with low-grade cancer were greater tumor size (endometrial thickness and volume), non-regular endometrial-myometrial junction and high color score. Non-endometrioid tumors had similar vascularity to Grade 3 endometrioid tumors but their morphology on grayscale ultrasound was similar to that of Grade 1 or 2 endometrioid tumors.
Selected sonographic characteristics of the endometrioid tumors in relation to their grade and Results are presented as median (range), n (%) or n/N (%). *In 30 cases, outcome was based on simple endometrial biopsy (n = 4), dilatation and curettage (n = 9) or hysteroscopic resection (n = 17), as hysterectomy showed no remaining cancer (normal findings (n = 17), atypical hyperplasia (n = 12) or simple hyperplasia (n = 1)). †In postmenopausal women. ‡Including 45 endometrioid tumors with squamous differentiation and two mucinous carcinomas.
stage (IA or ≥ IB) diagnosed at hysterectomy are shown in Table S2 . Irrespective of stage of endometrial cancer, higher tumor grade was associated with larger tumor, higher prevalence of non-uniform endometrial morphology and heterogeneous endometrium without cystic areas, and lower prevalence of regular endometrial-myometrial junction and no detectable vascularization. At the same time, irrespective of grade, tumors of Stage ≥ IB are larger compared with those of Stage IA, are more likely to have irregular endometrial-myometrial junction, non-uniform echogenicity and heterogeneous endometrium without cystic areas, color score 4 and multiple vessels with multifocal origin, but are less likely to have color score 1 and multiple vessels with focal origin. Sonographic features of low-vs high-risk cancer are presented in Table 3 . Higher stage and grade of cancer was associated with larger tumors (volume and endometrial thickness), lower prevalence of regular endometrial-myometrial junction and uniform endometrial echogenicity, increased color score, and higher prevalence of multiple, multifocal vessel pattern. The strongest discriminators between low-and high-risk cancer were tumor size (endometrial thickness and volume), color score, vessel pattern, and endometrial-myometrial junction. Figure 2 shows ultrasound images of endometrioid tumors of different stages and grades. Endometrial morphology on grayscale ultrasound and vascularization on color Doppler differed between women with endometrial thickness < 15 mm and those with thickness ≥ 15 mm. Women with endometrial thickness < 15 mm, compared with those with endometrial thickness ≥ 15 mm, were more likely to have regular endometrial-myometrial junction (37% (249/675) vs 14% (110/802)), uniform endometrial echogenicity (50% (340/675) vs 28% (221/802)) and hyperechogenic endometrium (42% (282/675) vs 18% (144/802)), while being less likely to have color score of 3 or 4 (41%, (275/675) vs 79%, (632/802)) and multiple vessels with multifocal origin (20% (138/675) vs 55% (438/802)).
Sonographic characteristics of non-endometrioid tumors (clear-cell carcinoma, serous carcinoma, mixed-cell carcinoma and carcinosarcoma) are presented in Table 4 . Since there were only seven women with undifferentiated tumors, we decided to exclude them from the table. Although low numbers were found for non-endometrioid tumors, carcinosarcomas and clear-cell carcinomas appeared larger than other non-endometrioid tumors. Uniform echogenicity was more prevalent in serous carcinomas and seen less often in mixed-cell carcinomas than in other types of non-endometrioid tumors. Figure 3 shows ultrasound images of endometrial cancer of non-endometrioid type. 
DISCUSSION
The aim of this large, prospective, multicenter study was to describe the sonographic features of endometrial cancer in relation to tumor stage and grade using the IETA consensus nomenclature 9 . In endometrioid tumors, a clear difference was found in morphological features between well-, moderately and poorly differentiated tumors. With increasing grade and stage, tumors were larger, had higher color score and were less likely to have regular endometrial-myometrial junction or uniform echogenicity (Tables 2, 3 and S2) . Non-endometrioid tumors were in general larger than endometrioid tumors, and had vascularity similar to that of Grade 3 endometrioid tumors, but grayscale morphology similar to Grades 1-2 endometrioid tumors (Tables 2 and 4 ).
Strengths of this study are the large study population, prospective design, participation of only experienced examiners, use of a standardized ultrasound examination protocol and an internet-based research database, into which cases could not be included unless all data were complete, thus improving the quality of data. The large sample size and the multicenter design increase the likelihood of our results being generalizable. Moreover, to the best of our knowledge, this is the first detailed description of the sonographic features of non-endometrioid endometrial cancers using standardized ultrasound terminology.
Our findings with regard to absolute tumor size and volume should be interpreted with caution, because most women had undergone various biopsy procedures before the ultrasound examination. Some might argue that it is a limitation of our study that all examinations were performed by ultrasound experts, impeding the generalizability of the results; however, according to the ESGO/ESMO/ESTRO consensus statement, assessment of extent of endometrial malignancies and identification of high-risk cases should be performed by ultrasound experts 5 , considering that they assess tumor extent more accurately and reproducibly than gynecologists not specialized in ultrasound imaging 14 . It is important to emphasize that this is a purely descriptive study on endometrial ultrasound morphology and vascularization and not a study on discriminative performance of different ultrasound variables. No individual sonographic parameter had more than a moderate ability to predict high-risk disease, and thus cannot on its own be used for discriminative purposes. This does not exclude that some sonographic parameters could be of value in a multivariable analysis, or to improve diagnostic confidence when subjectively assessing deep myometrial invasion and cervical stromal invasion. As part of the IETA4 collaboration, we attempt to construct risk prediction models for lymph-node metastases and high-risk disease, but this is beyond the scope of this paper.
In agreement with our results, a smaller series (n = 144) demonstrated previously that grayscale and vascular morphological characteristics of endometrial cancer were related to tumor stage, grade and size, and that advanced tumors manifested more often a mixed or hypoechogenic echogenicity, high color score and multiple vessels of multifocal origin 15 . We found that tumor size appeared to be the single strongest ultrasound predictor of high-risk disease. Other studies have also found that tumor size, according to the hysterectomy specimen 16 or MRI 17 , correlates to lymph-node metastases 16, 17 and disease-free survival in women with endometrial cancer 16 . In our study, we found that tumors <15 mm had regular endometrial-myometrial junction in 37% of cases and hyperechogenic endometrial echogenicity in 42%. These are also typical features of endometrial hyperplasia 18 . This is in line with a previous study showing that it was difficult to differentiate between benign and malignant endometrium in women with postmenopausal bleeding if the endometrium measured <15 mm 19 . Even though an irregular endometrial-myometrial junction is a feature of endometrial carcinoma 15,9-14,16-23 , we found it to be regular in 32% (299/911) of Stage 1A cancers, which is in agreement with the 27-30% found in previous publications 15, 23 . Future IETA studies could investigate if typical ultrasound features of premalignant endometrial lesions exist.
We also found that the color score increased with increasing tumor grade and stage. This is in agreement with other studies reporting that a high color density 24 or color score 15, 25 is associated with higher endometrial cancer stage 15, 24 and presence of nodal metastasis 25 , and that multiple vessels with multifocal origin are associated with higher tumor stage, higher grade, non-endometrioid tumors, larger tumor size and an infiltrative tumor growth pattern 15 . The higher prevalence of a multiple vessel pattern in high-risk tumors is interesting. Angiogenesis, as measured by microvessel density, has been demonstrated to play a role in endometrial cancer prognosis 26 . Vascular proliferation seems to be related to aggressive tumors and decreased survival 27 . It would be interesting to investigate in future studies if endometrial tumors richly vascularized with the multiple, multifocal vessel pattern on ultrasound have an increased expression of angiogenic markers and/or are associated with lymphovascular space invasion.
Over 30 years ago, Bokhman hypothesized that there are two pathogenic types of endometrial cancer: Type I and Type II 28 . Today we know that the condition is more complex and that histopathological assessment of endometrial tumors is only moderately reproducible within and between pathologists, indicating a need for more specific and accurate techniques to classify endometrial cancers 29 . Based on The Cancer Genome Atlas, research teams have developed molecular classifiers to identify four prognostically distinct molecular subgroups of endometrial cancer (polymerase-ε 'POLE' ultramutated, microsatellite instability hypermutated, copy number low and copy number high) [30] [31] [32] . It remains to be seen if sonographic morphology correlates to the genome-based classification and if the combination of ultrasound and molecular information can be used to optimize and personalize the management of women with endometrial cancer.
In conclusion, this study shows that sonographic morphological features described using the IETA terminology 9 are associated with the grade and stage of tumors and differ between high-and low-risk cancer. It remains to be seen whether supplementary assessment of endometrial grayscale ultrasound morphology and vascularization on color Doppler in addition to assessment of myometrial and cervical stroma invasion can improve identification of high-risk disease.
SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Table S1
Number of patients recruited into study from each participating center Table S2 Selected sonographic characteristics, according to IETA terminology, of endometrioid tumors (n = 1330) in relation to their grade and stage diagnosed at hysterectomy Figure S1 Definitions and terminology of International Endometrial Tumor Analysis (IETA) statement for description of sonographic features of endometrium and uterine cavity on unenhanced sonography and saline contrast sonohysterography.
